Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$45.44 - $74.26 $360,793 - $589,624
7,940 Added 0.68%
1,169,232 $76.8 Million
Q4 2022

Feb 14, 2023

BUY
$41.39 - $81.0 $19.1 Million - $37.4 Million
461,521 Added 65.95%
1,161,292 $52.2 Million
Q3 2022

Nov 14, 2022

BUY
$72.36 - $113.1 $2.67 Million - $4.17 Million
36,832 Added 5.56%
699,771 $50.6 Million
Q2 2022

Aug 15, 2022

BUY
$87.2 - $114.05 $7.58 Million - $9.91 Million
86,925 Added 15.09%
662,939 $71.1 Million
Q1 2022

May 16, 2022

BUY
$94.19 - $124.49 $8.07 Million - $10.7 Million
85,703 Added 17.48%
576,014 $63.9 Million
Q4 2021

Feb 14, 2022

BUY
$119.57 - $139.07 $19.1 Million - $22.2 Million
159,940 Added 48.41%
490,311 $62.8 Million
Q3 2021

Nov 15, 2021

BUY
$109.17 - $142.35 $4.9 Million - $6.39 Million
44,922 Added 15.74%
330,371 $44 Million
Q2 2021

Aug 16, 2021

SELL
$100.34 - $115.69 $3.22 Million - $3.71 Million
-32,101 Reduced 10.11%
285,449 $30.9 Million
Q1 2021

May 17, 2021

SELL
$101.51 - $125.27 $279,254 - $344,617
-2,751 Reduced 0.86%
317,550 $33.4 Million
Q4 2020

Feb 16, 2021

SELL
$85.88 - $105.36 $195,892 - $240,326
-2,281 Reduced 0.71%
320,301 $33.3 Million
Q3 2020

Nov 13, 2020

SELL
$72.74 - $92.5 $392,286 - $498,852
-5,393 Reduced 1.64%
322,582 $27.6 Million
Q2 2020

Aug 14, 2020

SELL
$48.02 - $79.04 $43,266 - $71,215
-901 Reduced 0.27%
327,975 $24 Million
Q1 2020

May 15, 2020

BUY
$36.95 - $62.95 $640,269 - $1.09 Million
17,328 Added 5.56%
328,876 $17.1 Million
Q4 2019

Feb 14, 2020

BUY
$47.06 - $56.64 $3.43 Million - $4.13 Million
72,852 Added 30.52%
311,548 $17.5 Million
Q3 2019

Nov 14, 2019

SELL
$47.45 - $58.05 $25,860 - $31,637
-545 Reduced 0.23%
238,696 $11.4 Million
Q2 2019

Aug 14, 2019

SELL
$39.26 - $54.21 $850,803 - $1.17 Million
-21,671 Reduced 8.31%
239,241 $13 Million
Q1 2019

May 15, 2019

BUY
$29.84 - $43.92 $7.79 Million - $11.5 Million
260,912 New
260,912 $10.6 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Snyder Capital Management L P Portfolio

Follow Snyder Capital Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Snyder Capital Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Snyder Capital Management L P with notifications on news.